Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,260.00
+60.00 (0.97%)
Last updated: Aug 24, 2026, 9:30 AM KST

KRX:000520 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6,1046,4125,137906.141,9033,992
Short-Term Investments
-----11,269
Cash & Short-Term Investments
6,1046,4125,137906.141,90315,261
Cash Growth
130.21%24.82%466.91%-52.40%-87.53%-11.26%
Accounts Receivable
33,06235,41735,02535,81334,18131,012
Other Receivables
108.16247.87754.7186.62123.85120.23
Receivables
33,17035,66535,77935,90034,30431,133
Inventory
31,75634,83334,77032,51124,74224,177
Prepaid Expenses
2,6761,84912,18911,159--
Other Current Assets
2,5413,1993,469638.2713,8326,140
Total Current Assets
76,24881,95891,34681,11574,78176,711
Property, Plant & Equipment
250,950242,715252,893242,198233,946103,394
Long-Term Investments
1,728819.59719.88797.39782.42838.64
Other Intangible Assets
3,7373,7274,7081,9173,1361,295
Long-Term Accounts Receivable
-0-01,033000
Long-Term Deferred Charges
1,6531,755804.2902.04--
Other Long-Term Assets
40,41640,62743,56743,75044,05444,167
Total Assets
374,731371,602395,071370,680356,700226,405

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
14,47119,17819,15921,00413,6608,541
Accrued Expenses
5,8405,2814,0543,2824,01311,153
Short-Term Debt
73,90965,84654,18474,86880,56275,733
Current Portion of Long-Term Debt
49,14674,6109,16449,8304,94016,560
Current Portion of Leases
705.86731.38685.6387.37452.59308.27
Current Income Taxes Payable
-386.871,6462,4171,949-
Current Unearned Revenue
17.3397.29123.72112.34179.99171.28
Other Current Liabilities
16,31219,03117,64516,77426,8369,208
Total Current Liabilities
160,403185,163106,660168,675132,592121,674
Long-Term Debt
51,13821,61484,39049,56871,91831,911
Long-Term Leases
1,1471,2221,6591,2251,3871,003
Long-Term Unearned Revenue
1,9321,8886.2736.3866.15222.65
Pension & Post-Retirement Benefits
24,33621,92116,99111,3106,6261,646
Long-Term Deferred Tax Liabilities
4,7794,6617,4939,75213,172-
Other Long-Term Liabilities
5,4461,8701,7482,2865,1204,202
Total Liabilities
249,181238,340218,947242,853230,881160,658

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10,84610,84610,8467,6136,8576,769
Additional Paid-In Capital
90,25986,43786,14544,00840,48135,248
Retained Earnings
-34,898-16,27919,93728,01926,60527,741
Treasury Stock
-1,749-2,517-2,517-4,161-4,142-5,431
Comprehensive Income & Other
61,09254,77661,71352,34956,0191,420
Shareholders' Equity
125,550133,262176,124127,827125,82065,746
Total Liabilities & Equity
374,731371,602395,071370,680356,700226,405

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
176,046164,023150,081175,879159,258125,515
Net Cash (Debt)
-169,943-157,611-144,944-174,973-157,355-110,254
Net Cash Growth
------
Net Cash Per Share
-7987.63-7424.11-8059.84-12095.82-11286.13-7972.68
Filing Date Shares Outstanding
21.3621.2321.2314.4614.2513.77
Total Common Shares Outstanding
21.3621.2321.2314.4614.2513.77
Working Capital
-84,155-103,204-15,314-87,560-57,811-44,964
Book Value Per Share
5877.296277.178296.138838.318830.454776.06
Tangible Book Value
121,813129,535171,416125,911122,68364,451
Tangible Book Value Per Share
5702.346101.638074.388705.798610.324681.97
Land
64,48764,48764,48764,48767,1492,501
Buildings
155,929146,477149,90047,13647,15446,000
Machinery
93,10387,78987,69844,84643,17844,758
Construction In Progress
215.881,91041.7132,199120,00955,341